Adenoid basal carcinoma of the cervix uteri

Adenoid basal carcinoma of the cervix uteri (also known as adenoid basal cell carcinoma of the cervix or adenoid basal epithelioma) is an extremely rare, low-grade malignant neoplasm arising from the uterine cervix. It is classified among the rare carcinomas of the cervix and is characterized by nests and cords of small, uniform basaloid cells that infiltrate the cervical stroma, often with a pattern resembling basal cell carcinoma of the skin. The tumor typically arises from the reserve cells of the cervical epithelium and predominantly affects postmenopausal women, most commonly in the sixth to seventh decades of life. It is strongly associated with high-risk human papillomavirus (HPV) infection, particularly HPV type 16. Clinically, adenoid basal carcinoma of the cervix is often asymptomatic and is frequently discovered incidentally during evaluation of abnormal cervical cytology (Pap smear) or in hysterectomy specimens removed for other indications. When symptoms are present, they may include abnormal vaginal bleeding, postcoital bleeding, or vaginal discharge. The tumor affects the female reproductive system, specifically the cervix uteri, including the endocervix (C53.0), exocervix (C53.1), and overlapping regions (C53.8). Importantly, this neoplasm has an indolent clinical course and an excellent prognosis, with metastasis being exceedingly rare in its pure form. Treatment typically involves surgical excision, most commonly simple hysterectomy, which is generally curative. Conservative management may be considered in select cases. Because of its rarity, there are no standardized chemotherapy or radiation protocols specific to this tumor. However, it is important to distinguish pure adenoid basal carcinoma from mixed tumors that contain components of more aggressive histologic types (such as adenoid cystic carcinoma or squamous cell carcinoma), as these mixed variants may carry a worse prognosis and require more aggressive treatment. Long-term follow-up is recommended, though recurrence in pure adenoid basal carcinoma is uncommon.

Common questions about Adenoid basal carcinoma of the cervix uteri